Literature DB >> 22803014

Tackling colorectal cancer as a public health issue: what can the gastroenterologist do?

Catherine Dubé.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22803014      PMCID： PMC3395440          DOI： 10.1155/2012/507989

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  10 in total

1.  Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance.

Authors:  Aafke H C van Roon; Janneke A Wilschut; Lieke Hol; Marjolein van Ballegooijen; Jacqueline C I Y Reijerink; Hans 't Mannetje; Laura J C Kranenburg; Katharina Biermann; Anneke J van Vuuren; Jan Francke; Alexandra C M van der Togt; Dik J F Habbema; Monique E van Leerdam; Ernst J Kuipers
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-23       Impact factor: 11.382

Review 2.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

3.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Authors:  Wendy S Atkin; Rob Edwards; Ines Kralj-Hans; Kate Wooldrage; Andrew R Hart; John M A Northover; D Max Parkin; Jane Wardle; Stephen W Duffy; Jack Cuzick
Journal:  Lancet       Date:  2010-04-27       Impact factor: 79.321

4.  Patients undergoing colorectal cancer screening underestimate their cancer risk and delay presentation for screening.

Authors:  Haili Wang; Nicholas Gies; Clarence Wong; Dan Sadowski; Barbara Moysey; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

5.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Authors:  Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

6.  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

Authors:  Leo G van Rossum; Anne F van Rijn; Robert J Laheij; Martijn G van Oijen; Paul Fockens; Han H van Krieken; Andre L Verbeek; Jan B Jansen; Evelien Dekker
Journal:  Gastroenterology       Date:  2008-03-25       Impact factor: 22.682

7.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Authors:  Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

8.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Authors:  L Hol; M E van Leerdam; M van Ballegooijen; A J van Vuuren; H van Dekken; J C I Y Reijerink; A C M van der Togt; J D F Habbema; E J Kuipers
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

9.  Colorectal cancer screening for average-risk North Americans: an economic evaluation.

Authors:  Steven J Heitman; Robert J Hilsden; Flora Au; Scot Dowden; Braden J Manns
Journal:  PLoS Med       Date:  2010-11-23       Impact factor: 11.069

10.  Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Authors:  L Sharp; L Tilson; S Whyte; A O'Ceilleachair; C Walsh; C Usher; P Tappenden; J Chilcott; A Staines; M Barry; H Comber
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640
  10 in total
  3 in total

Review 1.  Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.

Authors:  Jill Tinmouth; Emily T Vella; Nancy N Baxter; Catherine Dubé; Michael Gould; Amanda Hey; Nofisat Ismaila; Bronwen R McCurdy; Lawrence Paszat
Journal:  Can J Gastroenterol Hepatol       Date:  2016-08-14

Review 2.  Colorectal cancer: evolution of screening strategies.

Authors:  Daniel Sur; Marius Colceriu; Genel Sur; Emanuela Floca; Loredana Dascal; Alexandru Irimie
Journal:  Med Pharm Rep       Date:  2019-01-15

Review 3.  Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions.

Authors:  Ângela Marques-Magalhães; Tânia Cruz; Ângela Margarida Costa; Diogo Estêvão; Elisabete Rios; Pedro Amoroso Canão; Sérgia Velho; Fátima Carneiro; Maria José Oliveira; Ana Patrícia Cardoso
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.